Cargando…
Catestatin Increases the Expression of Anti-Apoptotic and Pro-Angiogenetic Factors in the Post-Ischemic Hypertrophied Heart of SHR
BACKGROUND: In the presence of comorbidities the effectiveness of many cardioprotective strategies is blunted. The goal of this study was to assess in a hypertensive rat model if the early reperfusion with anti-hypertensive and pro-angiogenic Chromogranin A-derived peptide, Catestatin (CST:hCgA(352–...
Autores principales: | Penna, Claudia, Pasqua, Teresa, Amelio, Daniela, Perrelli, Maria-Giulia, Angotti, Carmelina, Tullio, Francesca, Mahata, Sushil K., Tota, Bruno, Pagliaro, Pasquale, Cerra, Maria C., Angelone, Tommaso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123866/ https://www.ncbi.nlm.nih.gov/pubmed/25099124 http://dx.doi.org/10.1371/journal.pone.0102536 |
Ejemplares similares
-
Retraction: Catestatin Increases the Expression of Anti-Apoptotic and Pro-Angiogenetic Factors in the Post-Ischemic Hypertrophied Heart of SHR
Publicado: (2021) -
Catestatin Improves Post-Ischemic Left Ventricular Function and Decreases Ischemia/Reperfusion Injury in Heart
por: Penna, Claudia, et al.
Publicado: (2010) -
Catestatin: Antimicrobial Functions and Potential Therapeutics
por: Jati, Suborno, et al.
Publicado: (2023) -
Obligatory Role for Endothelial Heparan Sulphate Proteoglycans and Caveolae Internalization in Catestatin-Dependent eNOS Activation
por: Fornero, Sara, et al.
Publicado: (2014) -
Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival
por: Penna, Claudia, et al.
Publicado: (2013)